2008
DOI: 10.1186/cc6794
|View full text |Cite
|
Sign up to set email alerts
|

Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia

Abstract: Introduction Arginine vasopressin (AVP) is increasingly used to restore mean arterial pressure (MAP) in low-pressure shock states unresponsive to conventional inotropes. This is potentially deleterious since AVP is also known to reduce cardiac output by increasing vascular resistance. The effects of AVP on blood flow to vital organs and cardiac performance in a circulation altered by cardiac ischemia are still not sufficiently clarified. We hypothesised that restoring MAP by low dose, therapeutic level AVP wou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
28
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(33 citation statements)
references
References 37 publications
4
28
1
Order By: Relevance
“…Our findings are consistent with those reported by others [15, 21] that AVP-induced decrease of myocardial contractility is most likely due to a decreased CF. However, there was a lack of correlation between CF and corresponding decrease in LVDP and RPP induced by 0.2, U/L AVP in the early-stage endotoxemia, although positive correlation between CF and RPP in the late-stage was found (Figure 5(a)).…”
Section: Discussionsupporting
confidence: 94%
“…Our findings are consistent with those reported by others [15, 21] that AVP-induced decrease of myocardial contractility is most likely due to a decreased CF. However, there was a lack of correlation between CF and corresponding decrease in LVDP and RPP induced by 0.2, U/L AVP in the early-stage endotoxemia, although positive correlation between CF and RPP in the late-stage was found (Figure 5(a)).…”
Section: Discussionsupporting
confidence: 94%
“…29 AVP has been used in piglet models and is still an effective agent for achieving arterial hypertension. 26,29,41,42 …”
Section: Discussionmentioning
confidence: 99%
“…This hypothesis was supported by studies demonstrating benefits of exogenous AVP administration in MABP recovery following HS (22). While these studies suggest an important role for AVP in response to HS and indicate therapeutic potential for exogenous administration, pressor use can lead to complications including impaired organ perfusion (23, 24). Thus, we sought a physiologic approach to stimulate endogenous AVP release following HS during AAI.…”
Section: Discussionmentioning
confidence: 99%